Cheryl is a former Senior Vice President of CCTMC (2022-2023) and a Ph.D. candidate at MD Anderson. She is an incoming associate for McKinsey & Company. She works in the Stem Cell Transplant Department, where she studies cell-based immunotherapy for solid tumors. She is a Chinese Canadian who studied in the UK only recently came to the US for her PhD studies. In her spare time, Cheryl enjoys baking and doing embroidery.